Health News - Reduce Cholesterol. Learn about stroke, blood pressure, hyperlipidemia, diabetes, heart disease and other medical conditions.
A Member of the Healthscout Network
 Printer Friendly  Send to a Friend

Twofold Action Urged for Pre-Diabetes

Goal is to prevent progression to the full-blown disease and its huge costs

By Steven Reinberg
HealthDay Reporter

WEDNESDAY, July 23 (HealthDay News) -- Lifestyle changes, coupled with a reduction in heart disease risks, will go a long way toward preventing pre-diabetes from progressing to the full-blown disease, experts from the American Association of Clinical Endocrinologists (AACE) recommend.

Pre-diabetes occurs when blood sugar levels or impaired glucose tolerance is elevated, but not quite to the point defined as diabetes. More than 56 million Americans currently suffer from pre-diabetes, according to the U.S. Centers for Disease Control and Prevention.

Advertisement
Related Stories
 border=
Mistaken Beliefs About Cancer Abound
Fat Cells in Obese People Are 'Sick'
Nuts, Seeds, Popcorn Don't Boost Diverticulosis Risk
Related Videos
 border=
Nutrition and Cancer
Nutrition and Osteoporosis
Importance of Good Nutrition
Related Slides
 border=
Liposuction
Hyperlipidemia
Related Encyclopedia
 border=
Cholesterol


"Diabetes has become the major problem in the United States," Dr. Harold Lebovitz, a professor of medicine at the division of endocrinology and metabolism/diabetes at the State University of New York Health Sciences Center at Brooklyn, said during a noon teleconference Wednesday.

Lebovitz noted that diabetes is the main cause of kidney failure and most blindness in adults, and causes about 60 percent of cardiovascular diseases.

"The issue is, do you wait until patients really develop these catastrophic complications?" Lebovitz said. "Last year, it cost $170 billion in direct and indirect costs to take care of people with diabetes."

The growing epidemic of diabetes in the United States will continue to cost more, unless something is done to halt it, Lebovitz noted. "Diabetes starts at an earlier stage, called pre-diabetes," he said. "The question arises, should you wait for pre-diabetic patients to develop diabetes and the complications, or should you take a preventive approach?"

The AACE is pressing for aggressive action to keep pre-diabetes from progressing to full-blown diabetes. The first step involves lifestyle changes, such as diet and exercise. "It will cost a lot of money to develop lifestyle programs, but in the long run we will save trillions of dollars in health care," Lebovitz said.

Many people question whether pre-diabetes is actually disease, Lebovitz said. "The important message is that pre-diabetes is not something people don't have problems with," Lebovitz said. "Sure, they don't have any problems when they're 30, but when they're 50, they've had their heart attack and now they have an ulcer on the foot."

In addition to lifestyle changes, the AACE thinks that pre-diabetes needs to be treated more aggressively.

Since there are no drug therapies approved by the U.S. Food and Drug Administration for treating pre-diabetes, the AACE suggests another way to get them: Reduce the number at which blood sugar levels define diabetes. That would make current medications available to people who are now classified as pre-diabetic.

In addition, those who cannot modify their cardiovascular risk by lifestyle changes need to be treated for high blood pressure, high cholesterol, and should have medications to control blood sugar levels.

"The data show that there is a spectrum of severity, with the most severely affected approaching the risks of people with diagnosed type 2 diabetes," Dr. Daniel Einhorn, vice president of the AACE, said in a statement. "In these highest-risk individuals, who represent a minority, pharmacologic strategies may be appropriate if intensive lifestyle therapies fail. Regardless, all individuals at risk for diabetes should be aware of the level of their risk factors and be prepared to take action."

More information

For more information on diabetes, visit the American Diabetes Association.

SOURCES: July 23, 2008, teleconference with Harold Lebovitz, M.D., professor, medicine, division of endocrinology and metabolism/diabetes, State University of New York Health Sciences Center at Brooklyn, New York City; Daniel Einhorn, M.D., vice president, American Association of Clinical Endocrinologists, and medical director, Scripps Whittier Institute for Diabetes, La Jolla, Calif.

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 7/23/2008



Disclaimer: The information provided on this website is for educational purposes only and does not serve as a replacement for care provided by your own personal health care team. This website does not render or provide medical advice, and no individual should make any medical decisions or change their health behavior based on information provided here. All pertinent content provided on this website should be discussed with your personal physician to evaluate whether it has any relevance to or impact on your specific condition. Reliance on any information provided by this website is solely at your own risk.


Aug 28, 2008
Home
Search
Powered By HealthLine
New! For timely and trustworth health information, expert advice and much more, visit Heart Disease Connection
Patient Guide
News
Health Videos
Health Encyclopedia
Health News Archive
Affiliate Information
HealthScout Network
Contact Us
Newsletters
Privacy Policy
Terms of Use

We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service  

To find more information on specific conditions, please visit our partner sites: